News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
CNS Drug Development Resources|
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos
Advertisement

Emily Hardy

Advertisement

Director, Sales and Marketing, Lokavant, Inc.

Articles by Emily Hardy

The Future of Clinical Trials: Turning Data Chaos into Trial Intelligence

ByTodd Johnson,Emily Hardy,Rohit Nambisan
June 3rd 2022

Poll taken by leading biotech executives in clinical development addresses state of data quality and management.

Advertisement

Latest Updated Articles

  • The Future of Clinical Trials: Turning Data Chaos into Trial Intelligence
    The Future of Clinical Trials: Turning Data Chaos into Trial Intelligence

    Published: June 3rd 2022 | Updated:



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

2

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

3

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

4

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

5

Accelerating Site Payments with Agentic AI: See it in Action

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us